Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours
Clinical trial NCT03894540 · TERMINATED
Trial details
- NCT number
- NCT03894540
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-22
- Primary completion
- 2020-12-21
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.